Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.

Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the displayed ClinicalTrials.gov revision updates from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check38 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe label text containing the contact information was capitalized from 'Find contact information' to 'Find Contact Information', and the revision entry was updated to 'v3.7.0' in the history, indicating UI consistency and the latest version reference.SummaryDifference0.2%

- Check74 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history, reflecting an updated version of the record, while the previous revision (v3.6.5) was removed from the latest list.SummaryDifference0.1%

- Check95 days agoChange DetectedA new revision entry v3.6.5 has been added to the study history, and the previous v3.6.4 entry has been removed. This update reflects an updated version in the page’s history log.SummaryDifference0.1%

- Check109 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the page's history, replacing the previous Revision: v3.6.3. This indicates a minor update to the revision metadata of the page and does not modify study content.SummaryDifference0.1%

Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.